These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36162740)

  • 1. Acceptability of an intravaginal ring for simultaneously preventing HIV infection and pregnancy: Qualitative findings of the Kisumu Combined Ring Study, 2019.
    McLellan-Lemal E; Deaton SR; Betts JE; Ondenge K; Mudhune V; O'Connor SM; Nyagol B; Thurman AR; Doncel GF; Allen SA; Heffron R; Mugo NR;
    Contemp Clin Trials; 2022 Nov; 122():106935. PubMed ID: 36162740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences.
    Guthrie KM; Rosen RK; Vargas SE; Getz ML; Dawson L; Guillen M; Ramirez JJ; Baum MM; Vincent KL
    PLoS One; 2018; 13(5):e0197269. PubMed ID: 29758049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of a Long-Acting, Multipurpose Vaginal Ring: Findings from a Phase I Trial in the U.S. and Dominican Republic.
    Tolley EE; Zissette S; Taylor J; Hanif H; Ju S; Schwarz J; Thurman A; Tyner D; Brache V; Doncel GF
    J Womens Health (Larchmt); 2022 Sep; 31(9):1343-1352. PubMed ID: 35363574
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized controlled phase IIa clinical trial of safety, pharmacokinetics and pharmacodynamics of tenofovir and tenofovir plus levonorgestrel releasing intravaginal rings used by women in Kenya.
    Mugo NR; Mudhune V; Heffron R; Thomas KK; McLellan-Lemal E; Njoroge B; Peacock S; O'Connor SM; Nyagol B; Ouma E; Ridzon R; Wiener J; Isoherranen N; Erikson DW; Ouattara LA; Yousefieh N; Jacot TA; Haaland RE; Morrison SA; Haugen HS; Thurman AR; Allen SA; Baeten JM; Samandari T; Doncel GF
    Front Reprod Health; 2023; 5():1118030. PubMed ID: 37383290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model.
    Smith JM; Moss JA; Srinivasan P; Butkyavichene I; Gunawardana M; Fanter R; Miller CS; Sanchez D; Yang F; Ellis S; Zhang J; Marzinke MA; Hendrix CW; Kapoor A; Baum MM
    PLoS One; 2017; 12(10):e0185946. PubMed ID: 28982161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.
    Thurman AR; Schwartz JL; Brache V; Clark MR; McCormick T; Chandra N; Marzinke MA; Stanczyk FZ; Dezzutti CS; Hillier SL; Herold BC; Fichorova R; Asin SN; Rollenhagen C; Weiner D; Kiser P; Doncel GF
    PLoS One; 2018; 13(6):e0199778. PubMed ID: 29953547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.
    Vincent KL; Moss JA; Marzinke MA; Hendrix CW; Anton PA; Pyles RB; Guthrie KM; Dawson L; Olive TJ; Butkyavichene I; Churchman SA; Cortez JM; Fanter R; Gunawardana M; Miller CS; Yang F; Rosen RK; Vargas SE; Baum MM
    PLoS Med; 2018 Sep; 15(9):e1002655. PubMed ID: 30265679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study.
    Thurman AR; Brache V; Cochon L; Ouattara LA; Chandra N; Jacot T; Yousefieh N; Clark MR; Peet M; Hanif H; Schwartz JL; Ju S; Marzinke MA; Erikson DW; Parikh U; Herold BC; Fichorova RN; Tolley E; Doncel GF
    PLoS One; 2022; 17(10):e0275794. PubMed ID: 36215267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of intravaginal rings as a potential HIV prevention device in urban Kenya: behaviors and attitudes that might influence uptake within a high-risk population.
    Smith DJ; Wakasiaka S; Hoang TD; Bwayo JJ; Del Rio C; Priddy FH
    J Womens Health (Larchmt); 2008; 17(6):1025-34. PubMed ID: 18681822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Mixed-Methods Study Examining Adherence to and Acceptability of Intravaginal Rings for HIV Prevention: Behavioral Results of MTN-027.
    Bauermeister JA; Golinkoff JM; Carballo-Diéguez A; Giguere R; López D; Hoesley CJ; Chen BA; Anderson P; Dezzutti CS; Strizki J; Sprinkle C; Heard F; Hall W; Jacobson C; Berthiaume J; Mayo A; Richardson BA; Piper J;
    AIDS Behav; 2020 Feb; 24(2):607-616. PubMed ID: 30877580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Young Women's Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa.
    Minnis AM; Roberts ST; Agot K; Weinrib R; Ahmed K; Manenzhe K; Owino F; van der Straten A;
    AIDS Behav; 2018 Aug; 22(8):2662-2673. PubMed ID: 29560570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings.
    Thurman AR; Schwartz JL; Ravel J; Gajer P; Marzinke MA; Yousefieh N; Anderson SM; Doncel GF
    PLoS One; 2019; 14(5):e0217229. PubMed ID: 31107913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraceptive vaginal ring experiences among women and men in Kisumu, Kenya: A qualitative study.
    McLellan-Lemal E; Ondeng'e K; Gust DA; Desai M; Otieno FO; Madiega PA; Nyagol B; Makanga EM
    Front Womens Health; 2017 Mar; 2(1):. PubMed ID: 28845463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring.
    Stoner MCD; Browne EN; Gundacker HM; Hawley I; Chen BA; Hoesley C; Scheckter R; Piper J; Singh D; Song M; Liu A; van der Straten A
    PLoS One; 2022; 17(2):e0263664. PubMed ID: 35192655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.
    Thurman AR; Clark MR; Hurlburt JA; Doncel GF
    Int J Womens Health; 2013 Oct; 5():695-708. PubMed ID: 24174884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female and male partner perspectives on placebo Multipurpose Prevention Technologies (MPTs) used by women in the TRIO study in South Africa and Kenya.
    Wagner LD; Minnis AM; Shea J; Agot K; Ahmed K; van der Straten A
    PLoS One; 2022; 17(5):e0265303. PubMed ID: 35551318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development.
    Morrow Guthrie K; Vargas S; Shaw JG; Rosen RK; van den Berg JJ; Kiser PF; Buckheit K; Bregman D; Thompson L; Jensen K; Johnson T; Buckheit RW
    PLoS One; 2015; 10(12):e0145642. PubMed ID: 26695431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genital microbiota of women using a 90 day tenofovir or tenofovir and levonorgestrel intravaginal ring in a placebo controlled randomized safety trial in Kenya.
    Dabee S; Mugo N; Mudhune V; McLellan-Lemal E; Peacock S; O'Connor S; Njoroge B; Nyagol B; Thurman AR; Ouma E; Ridzon R; Wiener J; Haugen HS; Gasper M; Feng C; Allen SA; Doncel GF; Jaspan HB; Heffron R;
    Sci Rep; 2022 Jul; 12(1):12040. PubMed ID: 35835755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of a Tenofovir Disoproxil Fumarate Intravaginal Ring for HIV Pre-Exposure Prophylaxis Among Sexually Active Women.
    Dobkin A; McWalters J; Barnett R; Ray LL; Espinoza L; McGinn AP; Atrio JM; Keller MJ
    Sex Transm Dis; 2020 Dec; 47(12):819-824. PubMed ID: 33186337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation 3D-printed intravaginal ring for prevention of HIV and unintended pregnancy.
    Young IC; Srinivasan P; Shrivastava R; Janusziewicz R; Thorson A; Cottrell ML; Sellers RS; Sykes C; Schauer A; Little D; Kelley K; Kashuba ADM; Katz D; Pyles RB; García-Lerma JG; Vincent KL; Smith J; Benhabbour SR
    Biomaterials; 2023 Oct; 301():122260. PubMed ID: 37549505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.